Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZeneca
The merger would be one of the biggest pharma deals ever. AstraZeneca’s market capitalization stood at $264 billion as of …
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر IBB والمشاعر والاتجاه
The merger would be one of the biggest pharma deals ever. AstraZeneca’s market capitalization stood at $264 billion as of …
It notched convincing beats on analyst estimates with its second-quarter performance.
Specialist funds returned nearly 40% as AI drug discovery and deal activity attracted additional capital.
IBB delivered 44% returns in one year but swung 40% lower at its worst. IXJ grew steadily with half the …
Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as …
Established pharmaceutical giants have delivered lower volatility and higher income than clinical-stage biotech exposure over the past five years.
تحليل متعدد المزودين بالذكاء الاصطناعي